期刊文献+

非酒精性脂肪性肝病的中药单药研究 被引量:9

Research of Single Chinese Drug in Treatment of Nonalcoholic Fatty Liver Disease
下载PDF
导出
摘要 近年来,中医药在防治非酒精性脂肪性肝病方面取得不少进展,实验及临床研究发现,一些单味中药对于非酒精性脂肪性肝病具有明显的治疗效果,且不良反应小,展现了中医药治疗非酒精性脂肪性肝病的广阔前景。 In recent years, traditional Chinese medicine (TCM) has made great progress in prevention and treatment of nonalcoholic fatty liver disease (NAFLD). Numerous experimental and clinical studies have demonstrated that single Chinese drug has significant curative effect in the treatment of NAFLD with few toxic side effects. It may indicate that TCM could play an important role in the treatment of NAFID in the future.
出处 《中华中医药学刊》 CAS 2014年第4期783-785,共3页 Chinese Archives of Traditional Chinese Medicine
基金 中国中医科学院"名医名家传承"项目(CM20121007)
关键词 非酒精性脂肪性肝病 中药单药 中医 nonalcoholic fatty liver disease single Chinese drug traditional Chinese medicine
  • 相关文献

参考文献28

二级参考文献232

共引文献1036

同被引文献117

引证文献9

二级引证文献77

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部